share_log

科华生物(002022.SZ)发布前三季度业绩,净亏损1.22亿元

shanghai kehua bio-engineering (002022.SZ) released its performance for the first three quarters, with a net loss of 0.122 billion yuan

Zhitong Finance ·  Oct 21 17:19

shanghai kehua bio-engineering (002022.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue...

Financial news from the Zhitong Economics APP, shanghai kehua bio-engineering (002022.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue of 1.35 billion yuan, a year-on-year decrease of 29.09%. The net loss attributable to shareholders of the listed company was 0.122 billion yuan. The net loss deducting non-recurring profits and losses attributable to shareholders of the listed company was 0.145 billion yuan.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment